News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
787,019 Results
Type
Article (76234)
Company Profile (747)
Press Release (710038)
Section
Business (221966)
Career Advice (3070)
Deals (37796)
Drug Delivery (120)
Drug Development (88015)
Employer Resources (174)
FDA (17378)
Job Trends (16722)
News (376600)
Policy (36530)
Tag
Academia (2970)
Alliances (54997)
Alzheimer's disease (1363)
Approvals (17305)
Artificial intelligence (170)
Bankruptcy (352)
Best Places to Work (12552)
Biotechnology (514)
Breast cancer (198)
Cancer (1461)
Cardiovascular disease (124)
Career advice (2574)
Cell therapy (318)
Clinical research (69766)
Collaboration (526)
Compensation (266)
COVID-19 (2785)
C-suite (121)
Data (1428)
Diabetes (184)
Diagnostics (6677)
Earnings (88710)
Employer resources (152)
Events (123576)
Executive appointments (415)
FDA (18082)
Funding (455)
Gene therapy (217)
GLP-1 (712)
Government (4880)
Healthcare (20673)
Infectious disease (2884)
Inflammatory bowel disease (125)
Interviews (552)
IPO (17256)
Job creations (4650)
Job search strategy (2193)
Layoffs (479)
Legal (8854)
Lung cancer (216)
Manufacturing (234)
Medical device (14346)
Medtech (14351)
Mergers & acquisitions (20716)
Metabolic disorders (521)
Neuroscience (1719)
NextGen Class of 2024 (7558)
Non-profit (5052)
Northern California (1737)
Obesity (297)
Opinion (246)
Patents (126)
People (62351)
Pharmaceutical (152)
Phase I (21582)
Phase II (30382)
Phase III (22909)
Pipeline (532)
Postmarket research (3266)
Preclinical (9744)
Radiopharmaceuticals (258)
Rare diseases (288)
Real estate (7065)
Regulatory (24372)
Research institute (2637)
Resumes & cover letters (471)
Southern California (1508)
Startups (4065)
United States (16316)
Vaccines (649)
Weight loss (235)
Date
Last 7 days (631)
Last 30 days (2481)
Last 365 days (37807)
2024 (37636)
2023 (42487)
2022 (53866)
2021 (58634)
2020 (57543)
2019 (51182)
2018 (38914)
2017 (36049)
2016 (36485)
2015 (42690)
2014 (37184)
2013 (34396)
2012 (34877)
2011 (34906)
2010 (34258)
Location
Africa (1098)
Arizona (197)
Asia (47040)
Australia (8272)
California (4030)
Canada (1474)
China (318)
Colorado (183)
Connecticut (201)
Europe (107030)
Florida (550)
Georgia (145)
Illinois (450)
Indiana (245)
Maryland (685)
Massachusetts (3227)
Michigan (192)
Minnesota (316)
New Jersey (1161)
New York (1127)
North Carolina (883)
Northern California (1737)
Ohio (156)
Pennsylvania (954)
South America (1443)
Southern California (1508)
Texas (596)
Utah (116)
Washington State (441)
787,019 Results for "purdue pharma l p research and development new jersey".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Press Releases
Mitsubishi Tanabe Pharma America to Present New ALS Research at MNDA’s 35th International Symposium on ALS/MND
December 3, 2024
·
9 min read
Press Releases
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
October 9, 2024
·
4 min read
Press Releases
Innocan Pharma Provides its Annual “State of Research and Development” Update for 2024
December 12, 2024
·
12 min read
Press Releases
Noema Pharma Appoints Volker Knappertz, M.D., as Executive Vice President of Research & Development
December 18, 2024
·
2 min read
Pharm Country
FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose
Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*.
April 8, 2024
·
6 min read
Press Releases
Mitsubishi Tanabe Pharma America Unveils New ALS Research Findings at NEALS 2024 Annual Meeting
October 18, 2024
·
10 min read
Press Releases
Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program
December 20, 2024
·
4 min read
ProBio Expands Plasmid DNA and Viral Vector Production in New Jersey to Accelerate Delivery of Life-Changing Cell and Gene Therapies
ProBio Inc, a New Jersey-based contract development and manufacturing organization (CDMO), proudly announce the expansion of its plasmid DNA and viral vector manufacturing capabilities with the opening of a new state-of-the-art facility in Hopewell, New Jersey.
June 25, 2024
·
2 min read
Pharm Country
Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. is accepting proposals for investigator-initiated research (IIR) to examine the outcomes associated with the use of Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL).
March 28, 2023
·
6 min read
1 of 78,702
Next
